New U.S. drugs improve health

Updated 2018-05-20 14:35:02 China Daily

New drugs developed by pharmaceutical companies from the United States have played an important role in improving healthcare for Chinese, according to China Association of Enterprises with Foreign Investment.

International pharmaceutical companies, including those from the U.S., have kept investing in research and development of new drugs in China, which has also contributed to improved innovation and research capabilities for domestic pharmaceutical companies, said Zuo Yuzeng, chief for communications at the association's R& D-based Pharmaceutical Association Committee.

The committee is comprised of 40 international companies with pharmaceutical research and development capabilities, including 12 from the U.S., such as MSD and Xian Janssen, he said.

"The companies have brought many patent drugs to Chinese patients. Many were not available in China before, and have contributed to helping patients relieve pain and prolong life," the committee said.

A recent new drug that was introduced to China was Sirturo, developed by Xian Janssen Pharmaceutical, a subsidiary of U.S. company Johnson& Johnson.

The drug, the first new medication for tuberculosis worldwide for the past 45 years, has been administered in China since Feb 24, and initial results showed it is effective for patients with multidrug-resistant TB, according to Wang Bin, deputy head of disease control and prevention for the National Health Commission.

Asgar Rangoonwala, president of Xian Janssen, said the drug is now being used at 16 hospitals nationwide in a trial program.

In April, China Drug Administration approved a nine-way HPV vaccine, which works against up to nine types of HPV and was developed by U.S. company MSD. A similar vaccine, which was also developed by the company and works against four types of HPV, was approved by the administration in May last year.

Previously, no vaccines were available on the Chinese mainland to effectively prevent cervical cancer, the second most common cancer among Chinese women aged 15 to 44 after breast cancer, except a two-way HPV vaccine, driving many women to Hong Kong to receive such vaccines.

International pharmaceutical companies have also contributed to improved capacities in innovation and research of domestic companies through increasing research and development in China, partnering with domestic research institutes and providing training, according to R & D-based Pharmaceutical Association Committee.

"Some domestic international companies in recent years have been developing fast and they are catching up," said Zuo from the committee.

Also in the News

Nicole Kidman Recalls Oscar Glory: Loneliest Time
Showbiz2016/06/16 13:58November 15 2018 09:37:07

Nicole Kidman Recalls Oscar Glory: Loneliest Time

Attending Shanghai International Film Festival, Nicole Kidman talks about her role in "Grace of Monaco".

Labor Day Travel Peak Starts
Also in the News2014/05/01 12:16November 15 2018 09:37:07

Labor Day Travel Peak Starts

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'
Also in the News2014/04/18 13:18November 15 2018 09:37:07

Johnny Depp Delivers a Speech 'Evolve the Future' in 'Transcendence'

Hollywood star Johnny Depp's speech in the upcoming new film "Transcendence" has been disclosed on Friday, April 11th.

News:
China World Business Sports Showbiz Audio
Video:
C4 My Chinese Life The Sound Stage China Revealed Showbiz Video Travel Video
Photos:
China World Fun Travel Entertainment Sports
Travel:
Beijing Shanghai Guangzhou
Lifestyle:
Live Music Opera & Classical Movies Traditional Shows Exhibitions
Learn Chinese:
Chinese Studio Living Chinese Everyday Chinese Just For Fun Chinese Culture Buzzwords